The Valley Desk

NCT00023699 · Interventional trial

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Overall registry status Completed

Phase 2

Conditions Ovarian Cancer, Primary Peritoneal Cavity Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov